Hypoglycemia and Cardiovascular Disease: Exploring the Connections
Kishan Akhaury1, Anil Wanjari1, Arya Harshyt Sinha2
1Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Hypoglycemia, a side effect of diabetes treatment, increases mortality and cardiovascular risks, especially in patients with type 1 or type 2 diabetes. Clinicians must consider this risk when managing glucose levels.
Area of Science:
- Endocrinology
- Cardiology
- Diabetology
Background:
- Hypoglycemia is a known side effect of insulin and insulin secretagogues used to treat diabetes.
- Hypoglycemia can impair brain function and is linked to increased mortality and cardiovascular disease.
- Ventricular arrhythmias have been observed in individuals experiencing hypoglycemia.
Purpose of the Study:
- To explore the relationship between hypoglycemia, cardiovascular events, and mortality.
- To identify factors influencing the association between hypoglycemia and adverse cardiovascular outcomes.
- To highlight the heightened susceptibility of diabetic patients to hypoglycemia's cardiovascular effects.
Main Methods:
- Review of experimental studies investigating the mechanisms of cardiovascular events during hypoglycemia.
- Analysis of human studies examining the impact of hypoglycemia on cardiac function.
- Examination of recent research on confounding factors and comorbidities in the context of hypoglycemia and mortality.
Main Results:
- Confounding factors may partially explain the observed correlation between hypoglycemia and mortality.
- Comorbidities can exacerbate hypoglycemia, leading to increased mortality risk.
- Patients with type 1 and type 2 diabetes exhibit greater susceptibility to the cardiovascular consequences of hypoglycemia.
Conclusions:
- Clinicians should be aware of the increased cardiovascular risk associated with hypoglycemia, particularly in diabetic patients.
- Careful consideration of glucose-lowering treatments and glycemic targets is crucial for mitigating hypoglycemia-related risks.
- Understanding the interplay between diabetes, hypoglycemia, and cardiovascular health is essential for patient management.
More Related Videos
09:35A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
08:22Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
Published on: March 20, 2017
Related Concept Videos
Hypoglycemia and Glucagon
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes Mellitus: Type 2 and Gestational
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
